PMDA drug package insert
スパニジン点滴静注用100mg
PMDA Prescription drug · 日本化薬株式会社 · package insert Jul 26, 2023
Key facts
| Brand names | スパニジン点滴静注用100mg |
|---|---|
| Nonproprietary names | グスペリムス塩酸塩 |
| Companies | 製造販売元／日本化薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 免疫抑制剤 |
| Therapeutic category codes | 873999 |
| YJ codes | 3999417D1037 |
| Approval numbers | 22000AMX01787 |
| Package insert edition | 第1版 |
| Package insert date | Jul 26, 2023 |
| PMDA document key | 530191_3999417D1037_1 |
| PMDA company code | 530191 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: